Condition

Advanced NSCLC clinical trials and research

• 7Clinical trials
• 2Countries

Newest Advanced NSCLC clinical trials

All recruiting trials (7)

• HS-IT101 TIL therapy for advanced NSCLC in a single-arm study

  This study tests HS-IT101, a patient’s own tumor-infiltrating lymphocytes, given after conditioning with drugs and IL-2, in adults with advanced non-small cell lung cancer who have exhausted standard treatments.

  Recruiting Phase 1 Hangzhou Huasai Biomedicine Co., Ltd. · Shanghai · NCT07830342

• Evaluating HB0025 Injection for Advanced Solid Tumors

  This study is testing a new injection called HB0025 combined with chemotherapy to see if it can help people with advanced lung or endometrial cancer feel better and improve their treatment outcomes.

  Recruiting at 14 sites Phase 1/2 Huabo Biopharm Co., Ltd. · Baoding, Hebei and 13 other locations · NCT06758557

• Personalized treatment for advanced lung cancer using a vaccine, PD-1 inhibitor, and radiotherapy

  This study is testing a new personalized treatment for advanced lung cancer that combines a vaccine, a PD-1 inhibitor, and radiotherapy to see if it helps patients whose cancer has progressed after initial therapy.

  Recruiting at 2 sites The First Affiliated Hospital of Nanchang University · Nanchang, Jiangxi and 1 other locations · NCT06752057

• Personalized treatment combining a peptide vaccine, PD-1 inhibitor, and radiotherapy for advanced lung cancer

  This study is testing a new treatment for advanced lung cancer that combines a personalized vaccine, a PD-1 inhibitor, and radiotherapy to see if it helps patients who haven't responded to other therapies.

  Recruiting at 2 sites The First Affiliated Hospital of Nanchang University · Nanchang, Jiangxi and 1 other locations · NCT06752044

• Personalized vaccine and PD-1 inhibitor with radiotherapy for advanced lung cancer

  This study is testing a new treatment combining a personalized vaccine, a PD-1 inhibitor, and radiotherapy to see if it can help people with advanced lung cancer who haven't responded to previous therapies.

  Recruiting at 2 sites Phase 2 The First Affiliated Hospital of Nanchang University · Nanchang, Jiangxi and 1 other locations · NCT06751901

• Personalized treatment combining a DC vaccine, PD-1 inhibitor, and radiotherapy for advanced lung cancer

  This study is testing a new personalized treatment for advanced lung cancer that combines a special vaccine, a PD-1 blocker, and radiation to see if it helps patients whose cancer has not improved with previous therapies.

  Recruiting at 2 sites Phase 2 The First Affiliated Hospital of Nanchang University · Nanchang, Jiangxi and 1 other locations · NCT06751849

• T Cell Receptor Immunotherapy for Metastatic Non-Small Cell Lung Cancer

  This study is testing a new treatment for advanced lung cancer that uses special immune cells from patients' own tumors to see if it can help shrink their cancer.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT02133196

Related topics

Quick answers

How many Advanced NSCLC clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (6 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →